Somatosensory stimulation biases hand selection in motor tasks

Hand choice is an unconscious decision frequently made in daily life, whether it’s reaching for an object such as a cup or performing any other task.

Research reveals key role of mucin modification in muco-obstructive diseases

With each breath, a human may inhale thousands of harmful microbes into the lungs. Mucus, the gel-like moist substance coating the airways, is one of

September 25, 2024

OrbiMed and Third Rock’s Terremoto Biosciences raises $175M for small molecule R&D

Terremoto Biosciences has reeled in $175 million to create small molecules based on work from Principia Biopharma co-founder Jack Taunton and Global Blood Therapeutics co-founder

November 3, 2023

Novel Drug Approved for All Duchenne Muscular Dystrophy Variants

The FDA approved oral givinostat (Duvyzat) to treat Duchenne muscular dystrophy (DMD) in patients ages 6 years and older, the agency announced Thursday. Givinostat is

March 23, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.